Trials / Completed
CompletedNCT02583880
Screening Day Latin America
Screening Day Latin America to Assess Disease-related Malnutrition and Clinical Nutrition Practice in ICU Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,162 (actual)
- Sponsor
- Fresenius Kabi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a survey which will be performed on a specific day (the "Screening Day") in Latin American ICUs. In eligible patients who receive enteral or parenteral nutrition a retrospective calculation of the "caloric deficit" will be performed. The caloric deficit is the difference between energy target of each patient and actually administered calories.
Detailed description
The Screening Day Latin America is a non-interventional, cross-sectional and retrospective study. The study focusses on patients receiving enteral (tube feeding, EN) and/or parenteral nutrition (PN). All patients hospitalized on the defined Screening Day in participating ICUs will be checked for eligibility. In eligible patients the patient charts will be reviewed and the following parameters will be documented: * Caloric deficit (daily target energy - actually administered energy via EN and PN). The caloric deficit will be calculated for 1 to up to 5 days before the Screening Day. The analysis will be done for each day and for the complete documentation period up to 5 days. Primary focus will be the caloric deficit on Day -1. * Nutritional status of the patient based on information from the patient charts. For this, three tools will be applied independently: Subjective Global Assessment (SGA), NUTRIC Score, ESPEN diagnosis of malnutrition The study will be performed in 8 Latin American countries. Data will be recorded anonymously in an electronic case report form. The study data of this explorative study will be analyzed using descriptive statistical methods.
Conditions
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2015-10-22
- Last updated
- 2016-12-20
Locations
121 sites across 8 countries: Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Panama, Peru
Source: ClinicalTrials.gov record NCT02583880. Inclusion in this directory is not an endorsement.